Concepedia
Statistics
Publications
7
Citations
289
H-Index
Active since
2018
Affiliations
Hubei University of Medicine(Current)
Shenzhen Third People’s Hospital
Southern University of Science and Technology
Guangzhou Medical University
Anhui Medical University
Yezi Wu is an author at Hubei University of Medicine specializing in tumor biology, cell signaling, and medicine.
Top concepts
MedicineCell BiologyTumor BiologyCell SignalingRadiation OncologyOncologyAutophagyPathologyCell DeathLung Cancer
Publications per year
2018–2024
RETRACTED: Polyphyllin I inhibits growth and invasion of cisplatin-resistant gastric cancer cells by partially inhibiting CIP2A/PP2A/Akt signaling axis
Yunfei Zhang, Ping Huang, Xuewen Liu et al. · Journal of Pharmacological Sciences · 2018 · 70 citations · Full text
Multiomics approach reveals the ubiquitination-specific processes hijacked by SARS-CoV-2
Gang Xu, Yezi Wu, Tongyang Xiao et al. · Signal Transduction and Targeted Therapy · 2022 · 59 citations · Full text
Polyphyllin I activates AMPK to suppress the growth of non-small-cell lung cancer via induction of autophagy
Yezi Wu, Yuan Si, Yuchen Xiang et al. · Archives of Biochemistry and Biophysics · 2020 · 49 citations · Full text
Chemoprevention Strategy, Cellular Physiology, Tumor Biology +16
Cucurbitacin B Inhibits the Hippo-YAP Signaling Pathway and Exerts Anticancer Activity in Colorectal Cancer Cells
Yanting Chai, Ke Xiang, Yezi Wu et al. · Medical Science Monitor · 2018 · 40 citations · Full text
Chemoprevention Strategy, Cell Death, Pathology +20
Cucurbitacin B induces inhibitory effects via the CIP2A/PP2A/C-KIT signaling axis in t(8;21) acute myeloid leukemia
Wenjing Ma, Yuchen Xiang, Rui Yang et al. · Journal of Pharmacological Sciences · 2019 · 35 citations · Full text
1–5 of 7